… The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients
with chronic obstructive pulmonary disease (COPD) is much debated, since it can result in …

… The systemic side effects commonly associated with oral glucocorticosteroids are largely
absent with inhaled corticosteroids at doses up to 400 ,g/day. But at doses greater than 400 ,ug/…

… of asthma, ciclesonide was observed to … efficacy, suggest that ciclesonide may have an
improved therapeutic margin compared with some other currently available inhaled corticosteroid …

Background: Various combinations of inhaled corticosteroid (ICS), long-acting muscarinic
antagonist (LAMA), and long-acting beta-agonist (LABA) have been used as triple therapy for …

… Many clinics give inhaled corticosteroids to patients with … efficacy and safety data on the use
of inhaled corticosteroids in … In contrast, knowledge about the use of inhaled corticosteroids …

… Beclomethasone dipropionate (BDP) was introduced in the early 1970s as the first inhaled
corticosteroid (ICS) to show enhanced topical to systemic activity (ie, therapeutic index) (3). …

… on the scientific evidence supporting treatment with inhaled corticosteroids (ICS) in COPD, …
drawn as to the efficacy and safety of ICS and LABA/ICS in the treatment of COPD (table 1). …

… This article reviews the pharmacological properties of the inhaled corticosteroids used in …
for the efficacy and safety of on-demand, compared with continuous inhaled corticosteroid …

… through the inhaled route, inhaled corticosteroids were developed and were first introduced
in 1973. Inhaled corticosteroids: efficacy in asthma Inhaled corticosteroids (ICS) have …

… Inhaled corticosteroids (ICSs) are a mainstay of COPD treatment for … safety profile of ICSs
in COPD patients is confounded by comorbidities, age, and prior use of systemic corticosteroids…